Athira Pharma, Inc. is a late clinical-stage biopharmaceutical company developing small molecules to restore neuronal health and stop neurodegeneration brought on by Alzheimer's disease and Parkinson's disease. The company's lead candidate, ATH-1017, is in human studies for Alzheimer's disease.Known as M3 Biotechnology, Inc. until 2019/04, the company was incorporated in 2011 and is headquartered in Bothell, WA.
What is Athira Pharma's quote symbol?
What is the 52 week high and low for Athira Pharma (NASDAQ: ATHA)?
How much is Athira Pharma stock worth today?
How much is Athira Pharma's stock price per share?
What is Athira Pharma's Market Cap?